Cargando…
Norepinephrine as a Potential Aggravator of Symptomatic Cerebral Vasospasm: Two Cases and Argument for Milrinone Therapy
Background. During hypertensive therapy for post-subarachnoid hemorrhage (SAH) symptomatic vasospasm, norepinephrine is commonly used to reach target blood pressures. Concerns over aggravation of vasospasm with norepinephrine exist. Objective. To describe norepinephrine temporally related deteriorat...
Autores principales: | Zeiler, F. A., Silvaggio, J., Kaufmann, A. M., Gillman, L. M., West, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241707/ https://www.ncbi.nlm.nih.gov/pubmed/25431686 http://dx.doi.org/10.1155/2014/630970 |
Ejemplares similares
-
Early Angiographic Resolution of Cerebral Vasospasm with High Dose Intravenous Milrinone Therapy
por: Zeiler, F. A., et al.
Publicado: (2015) -
The use of intravenous Milrinone to treat cerebral vasospasm following traumatic subarachnoid hemorrhage
por: Lasry, Oliver, et al.
Publicado: (2014) -
Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review
por: Santos-Teles, Alex Goes, et al.
Publicado: (2020) -
Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study
por: Soliman, Rabie, et al.
Publicado: (2018) -
Left Ventricular Outflow Tract Obstruction in Patients Treated With Milrinone for Cerebral Vasospasm: Case Report and Literature Review
por: Baulier, Charles, et al.
Publicado: (2022)